Global Alzheimers Drug Market: Trends,

Opportunities and Forecasts (2015-2020)

(c) AZOTH Analytics

December
1
2015

Table of Content
Figure No.

Title

Page No.

Research Methodology

Alzheimers Disease Market Overview

Global Alzheimers Disease Market Outlook

Global Alzheimers Disease Market

4.1

By Therapeutics

4.2

By Diagnostics and Biomarkers

4.3

By Imaging Sector

4.4

By Disease Modifying Therapeutics

Global Alzheimers Disease Market Outlook-By Demographic (Age-Group)

Global Alzheimers Disease Market Outlook-By Drug

Global Alzheimers Disease Market Outlook-By Region

United States Alzheimers Disease Market Outlook

7.1

(c) AZOTH Analytics

United States Dementia Market Outlook

Table of Content
Figure
No.

10

Title

Page No.

9.3

Australia Dementia Market Outlook

9.4

UK Dementia Market Outlook

Market Dynamics
10.1

Drivers

10.2

Challenges

11

Market Trends & Developments

12

Competitive Landscape
12.2

Sales Comparatives, Top 5 Companies

12.3

EBITDA Comparatives, Top 5 Companies

12.4

EBIT Comparatives, Top 5 Companies

12.5

PBT Comparatives, Top 5 Companies

12.6

PAT Comparatives, Top 5 Companies

(c) AZOTH Analytics

12.7

Current Ratio Comparatives, Top 5 Companies

Table of Content
Figure
No.

13

Title

Page No.

12.8

Profit Margin Ratio Comparatives, Top 5 Companies

12.9

Debt-Equity Ratio Comparatives, Top 5 Companies

About Us & Disclaimer

(c) AZOTH Analytics

List of Figures
Figure No.

Title

Page No.

Figure 1:

Global Alzheimers Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in
Million) 2010-2020F

Figure 2:

Global Alzheimers Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F

Figure 3:

Global Alzheimers Market share, By Therapeutics

Figure 4:

Global Alzheimers Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)

Figure 5:

Global Alzheimers Disease Market, By Imaging Sector, By Value (USD Million)x`

Figure 6:

Global Alzheimers
Million)

Figure 7:

Global Alzheimers Disease Market, By Demographics, By Age < 65, By Volume (Number of patients in
million),2010-2020F

Figure 8:

Global Alzheimers Disease Market, By Demographics, By Age > 65, By Volume (Number of patients in
million),2010-2020F

Figure 9:

Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patients
in Million) 2010-2020F

Figure 10:

United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In
Million) 2010-2020F

Figure 11:

Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14

Figure 12:

U.S. Alzheimers Drug RTV-101 Market , By Value & Penetration Rate; 2019-2027 (USD Million)

Figure 13:

U.S. Alzheimers Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)

Disease

Market by Disease Modifying Therapeutics

(c) AZOTH Analytics

Market Size ,By Value (USD

List of Figures
Figure No.

Title

Page No.

Figure 16:

Global Dementia Disease Market Size ,By Value (USD Million)

Million) 2010-2020F

Figure 17:

Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014

Figure 18:

Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients In
Million), By Region 2014

Figure 19:

Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country
2015E,2030F,2050F

Figure 20:

Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014

Figure 21:

Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million)
2010-2020F

Figure 22:

Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million)
2010-2020F

Figure 23:

Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 20102020F

Figure 24:

Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F

Figure 25:

Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F

Figure 26:

UK Dementia Market, By Type, 2014 (%)

Figure 27:

UK Dementia Cost, By Type of Service, 2014 (%)

Figure 28:

Number of Unpaid Caregivers (In Million)

(c) AZOTH Analytics

and Volume (Number of Patients In

List of Figures
Figure No.

Title

Page No.

Figure 32:

Novartis International AG Revenue (USD Million) AY 2011-2014

Figure 33:

Novartis International AG Percentage Revenue, By Business Segment (2014)

Figure 34:

Novartis International AG Percentage Revenue, By Geography (2014)

Figure 35:

Axovant Services Ltd. Revenue (USD Million) FY 2011-2015

Figure 36:

Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)

Figure 37:

Axovant Services Ltd. Percentage Revenue, By Geography (2014)

Figure 38:

Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014

Figure 39:

Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)

Figure 40:

Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)

Figure 41:

Biotie Therapies Revenue (USD Million) AY 2011-2014

Figure 42:

Biotie Therapies Percentage Revenue, By Business Segment (2014)

Figure 43:

Sales Comparatives, Top 5 Companies, 2011-2014

Figure 44:

EBITDA Comparatives, Top 5 Companies, 2011-2015

(c) AZOTH Analytics

Research Methodology
Research Definition
Global Alzheimers disease Market Report comprises of the study of various aspects of Alzheimers Market and
forecast until 2020. The Alzheimer Disease Market has been segmented on basis of type of disease and type of
medical ailment and on regional basis globally.
Data Analysis and Interpretation
Our historic market trend has been figured out by various paid databases which was further triangulated with various
secondary research sources along with primary interviews with the industry professionals/experts. Back-of-theEnvelope calculation for the market estimation has been made through proper understanding of the market as well as
future business strategies of the companies involved in the market.
Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market
segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by
reaching out industry experts across the Alzheimers disease market.
For Forecasting purposes, we have accessed some of the paid databases such as Bloomberg, Reuters, Factiva, and Hoovers.
Companies Contacted
Pfizer Inc., Novartis International AG, Axovant Sciences Ltd.,Acadia Pharmaceuticals, Biotie Therapies
(c) AZOTH Analytics

Alzheimers Disease Market Overview

Figure 1: Global Alzheimers Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in
Million) 2010-2020F

10

11
2.0

2010
1.0

21
20 12.0
19 11.0
18
17
16
15
14
13
12
10.0
9.0
8.0
6.0 7.0
3.0 4.0 5.0

2011

2012

2013

2014

2015E

Market Value

2016F

2017F

2018F

2019F

2020F

Number of Patients

Figure 2: Global Alzheimers Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F

1.00

1.10

1.20

1.30

2010

2011

2012

2013

1.40

1.50

1.60

1.70

2014

2015E

2016F

2017F

(c) AZOTH Analytics

1.80

1.90

2.00

2018F

2019F

2020F

Alzheimers Disease Market Overview

Figure

3:

Global

Alzheimers

Market

share,

By

Therapeutics

25%

Figure 3: Global Alzheimers Market share, By Region,

2014(In %)

Disease Modifying
Therapeutics

25%

3%

Diagonistics and Bio

Markers

22%

Imaging Sector

25%

25%

Figure 9: Global

25%

25% 25%

Therapeutics for
treatment of symtoms

Asia Pacific

America's

Europe

Africa

Row

Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of

Patients in Million) 2010-2020F

10.30 10.40
10.20
10.00 10.10
2010

2011

2012

2013

2014

10.50

2015

10.90 11.00
10.80
10.60 10.70

2016

(c) AZOTH Analytics

2017

2018

2019

2020

10

Alzheimers Disease Market Overview

Figure 11: Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14

Figure 15: U.S. Annual Alzheimers Death Rates ,By Age; 2006-2013
Medicare

60.00
50.00
40.00

Medicade

Out of Pocket

Other

50.20 49.50 47.00

42.90 40.50 39.00
36.00 34.00 33.50 33.40

30.00
20.00
10.00
0.00

(c) AZOTH Analytics

11

Alzheimers Disease Market Overview

Figure 17: Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In
Million) 2010-2020F

10
2010
1

11
2

12
3

13
4

14
5

2011

2012

2013

2014

Number of Patients

15
6

2015E

16
7
2016F

17
8
2017F

18
9
2018F

1019

1120

2019F

2020F

Value of the market

Figure 17: Global Dementia Disease Market Size , By

Figure 18: Global Dementia Disease Market Size , By

Volume (Number of Patients In Million), By Region

Number of new cases, By Volume (Number of Patients

2014

In Million), By Region 2014

(c) AZOTH Analytics

12

Alzheimers Disease Market Overview

Figure 22: Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million)
2010-2020F

15.79 16.18 16.59 17.00 17.42 17.86 18.31 18.76 19.23 19.71 19.91

2010

2011

2012

2013

2014

2015E

2016F

2017F

2018F

2019F

2020F

Figure 22: Global Dementia Disease Market Size High Income Countries ,Volume (Number of Patients In Million)
2010-2020F

15.79 16.18 16.59 17.00 17.42 17.86 18.31 18.76 19.23 19.71 19.91

2010

2011

2012

2013

2014

2015E

2016F

(c) AZOTH Analytics

2017F

2018F

2019F

2020F

13

Alzheimers Disease Market Overview

Figure 23: Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 20102020F

9.5
China

4.2

4.1

3.1

US

India

Japan

1.6

1.6

1.3

1.2

1.2

1.2

Brazil

Germany

Russia

Italy

Indonesia

France

Figure 26: UK Dementia Market, By

Type, 2014 (%)
Figure 24: Australia Dementia Disease Market Size , By Volume
(Number of Patients In Million) 2010-2020F

11.00
10.00
6.007.008.009.00
5.00
4.00
2.003.00
1.00

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

(c) AZOTH Analytics

Source: Azoth Analytics

Alzheimer's
Disease
Vascular
Dementia
Mixed
Dementia
Dementia
with Lewy
Bodies
Frontotemp
oral
Dementia

14

Global Alzheimers Drug Market: Trends, Opportunities and Forecasts (2015-2020)

(By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)

Number of Pages: 106

Price: US$ 2000 (Single User)
Price: US$ 3000 (Multi-User)
Order Online:
http://www.azothanalytics.com/report/global-alzheimer%E2%80%99s-drug-market-trends-opportunities-and-forecasts-2015-2020-r4
Contact Details
Contact Person: Subhodeep Sen
E-mail: info@azothanalytics.com
Phone Number: Tel: +91 120 429 8235
24/7 Helpline Number: +91 9873 4262 88

About Azoth Analytics Pvt Ltd.

Our business research and market analysis helps organizations across different industry verticals solve their business problems. In our
reports, historic market trend is figured out by various paid databases which is further triangulated with inputs and insights from industry
experts through primary research. Back-of-the-Envelope calculation for the market estimation is being made through proper understanding
of the market as well as future business strategies of the companies engaged in the market. Our detailed research reports help our clients
and customers get clear understanding of a specific industry or vertical of a designated country or region and make informed decision
pertaining to market entry or expansion, strategic alliances or partnerships, product launch or brand positioning.

(c) AZOTH Analytics

15